Best Life Sciences Companies in Fort Worth, United States
The 36 best Life Sciences companies in Fort Worth, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Alcon.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Fort Worth
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Alcon Developer of a wide range of eye care products | $187M | 84 mo ago | Public | David Endicott CEO | 1945 | DrupalPHPVarnish+17 | 533 patents Modular intraocular lens systems and real-time ophthalmic surgical navigation technologies. | — |
| 2 | Actuate Therapeutics Developer of therapeutics for hard-to-treat cancer | $72M | 14 mo ago | Public | Dan Schmitt President and CEO | 2015 | WordPressMySQLPHP+16 | — | 1 launch |
| 3 | Xequel Bio Developer of therapeutics for multiple indications | $63M | 19 mo ago | Series B | Jerry Peter CEO | 2005 | — | — | — |
| 4 | Nacuity Pharmaceuticals Developer of therapies for treating retinitis pigmentosa | $31M | 9 mo ago | Series B | Halden Conner CEO & President | 2016 | WordPressMySQLPHP+16 | — | — |
| 5 | Encore Vision Liquid therapeutic solution for presbyopia patients | $16M | 124 mo ago | Acquired | — | 2000 | — | 36 patents Stabilized lipoic‑acid choline ester formulations for ophthalmic drug delivery | — |
| 6 | SteadMed Wound, skin and incontinence therapy products | $3M | 182 mo ago | Series A | Michael E. Steadman CEO & President | 2010 | — | — | — |
| 7 | Cx Precision Medicine Developer of blood-based biomarker screening technology, diagnostics, and other | $2M | 45 mo ago | Seed | Danguole Altman President and CEO | 2016 | — | 63 patents Gene expression profiling for disease diagnosis, prognosis, and therapy response monitoring | — |
| 8 | MedHab Remote patient monitoring and therapeutic devices for improved health and performance | $2M | 98 mo ago | Seed | — | 2008 | — | 33 patents Wearable health monitoring devices for fall detection, gait analysis, and activity tracking | — |
| 9 | LipoMedics Developing innovative phospholipid bound nanoparticle formulations for drug delivery | $1M | 123 mo ago | Seed | Tapas DE CEO | 2015 | — | — | — |
| 10 | Eosera Doctor-recommended ear care solutions for earwax, pain, and itch relief | $1M | 33 mo ago | Seed | — | 2015 | ShopifyReactstyled-components+32 | 5 patents Topical otic formulations for cerumen (earwax) removal and treatment | — |
| 11 | E-Mist Innovations Electrostatic System for Infection Control | $1M | 112 mo ago | Seed | George Robertson CEO | 2010 | WordPressMySQLPHP+25 | — | — |
| 12 | Vitafive Delicious, low-sugar gummy vitamins for the whole family's health | $863K | 77 mo ago | Seed | Nikolas Hall Co-Founder & President | 2015 | Cart FunctionalityShopifySentry+30 | — | — |
| 13 | FYR Medical Developer of surgical loupes and optical devices | $725K | 54 mo ago | Seed | Chris Silva CEO | 2021 | — | — | — |
| 14 | Barricade Therapeutics Barricade Therapeutics is a privately held biotech company. | — | 21 mo ago | Funding Raised | Neil Thapar CEO | 2017 | — | — | — |
| 15 | PolyMem Advanced wound care solutions promoting healing, pain reduction, and inflammation control | — | 45 mo ago | Funding Raised | — | 1977 | Cart FunctionalityWordPressApple iCloud Mail+21 | — | — |
| 16 | Fuse Medical Provider of orthopedic implants and tools | — | 97 mo ago | Public | Christopher Pratt CEO | 1968 | WordPressMySQLPHP+21 | — | — |
Top 12 Life Sciences companies in Fort Worth
#1
Series B · Fort Worth, Texas · founded 2016 · 7 employees$30.9Mraised▾
Nacuity Pharmaceuticals is developing therapies for treating retinitis pigmentosa and other ophthalmological disorders. The company's lead candidate NPI-001 is used for treating retinitis pigmentosa, NPI-002 for prevention or treatment of cataract, and NPI-001 Ophthalmic Insert for the treatment of ocular effects of Cystinosis.
- Dec 2025Series B$8.4M
- Jun 2022Series B$16.5M
- Mar 2021Series A$3.2M
- Jul 2017Series A$9.2M
#2
Public · Fort Worth, Texas · founded 2015 · 6 employees$72.2Mraised▾
Developer of therapeutics for hard-to-treat cancer. It offers a lead drug candidate elraglusib a GSK-3β inhibitor that also modulates antitumor immunity to slow tumor growth and counteract resistance. It is used for the treatment of melanoma, pediatric cancer, pancreatic cancer, and others.
- Jun 2025Post IPO$4.7M
- Feb 2024Series D$3M
- Dec 2022Series D$19.3M
- Dec 2020Series C$14.5M
#3
Series B · Fort Worth, Texas · founded 2005 · 16 employees$63.2Mraised▾
Developer of therapeutics for multiple indications. It offers drug formulation of alpha-connexin carboxyl-terminal 1 peptide technology platform which includes Granexin Gel a topical formulation for dermatology and wound healing, iNexin Eye Drops for corneal and retinal diseases, and inhalation solution for pulmonology.
- Jan 2025Grant (prize money)$776.5K
- Apr 2021Series B$26.7M
- Mar 2019Series B$11.7M
- Jan 2018Series B$15M
#4
Public · Fort Worth, Texas · founded 1945 · 1001 employees$186.6Mraised▾
Developer of a wide range of eye care products. It is a medical technology company that specializes in developing eye care treatments and products, focusing on contact lenses, surgical devices, and pharmaceuticals for various eye conditions. It develops, manufactures, and markets pharmaceuticals, surgical equipment and devices, contacts lens solutions, and other vision care products that treat diseases, disorders, and other conditions of the eye.
#5
Seed · Fort Worth, Texas · founded 2015 · 16 employees$1.3Mraised▾
Doctor-recommended ear care solutions for earwax, pain, and itch relief. We are dedicated to providing safe, effective, and easy-to-use over-the-counter ear care products. We offer clinically proven earwax dissolving drops, doctor-recommended ear pain relief, and natural botanical sprays for dry, itchy ears. Our products address common issues like earwax impaction, ear pain, and ear itch due to allergies, earbuds, hearing aids, and skin conditions. We collaborate with leading doctors and listen to consumers to create a comprehensive range of products. We focus on empowering consumers to improve their ear health with high-quality healthcare products. We also run a pitch competition for women-led businesses, fostering innovation and opportunity.
- Dec 2023Seed$1.3M
- Feb 2016Conventional Debt$25K
#6
Acquired · Fort Worth, Texas · founded 2000 · 1 employees$16Mraised▾
Encore Vision, is an ophthalmic therapeutic company formed to develop treatments for presbyopia, directed at its primary cause. The company is pursuing the hypothesis that presbyopia can be treated and/or prevented by reducing the aberrant chemical bonds, which form in the human crystalline lens, resulting in increasing lens stiffness with age. In Jan 2001, a patent application was filed for this invention, which was issued in Aug 2005. Encore Vision’s technology is protected by a growing patent portfolio which includes 9 US issued, 20 Foreign issued, 19 pending and 2 Provisional applications. In May 2016, the company announced the successful completion of its EV06 solution.
- May 2016Series A$4.5M
- Feb 2015Series A$1.1M
- Sep 2014Series A$1.7M
- Dec 2013Series A$5M
#7
Seed · Fort Worth, Texas · founded 2016 · 3 employees$2.1Mraised▾
Developer of neurodegenerative therapeutics designed to develop blood-protein screening technology and companion diagnostics for therapeutic agents. The company focuses on patients suffering from Alzheimer's and other degenerative nerve diseases by developing blood-based biomarker tools to accelerate diagnosis and improve patient outcomes through personalized therapeutic treatments, helping physicians to treat patients with the right medicines more quickly.
- Dec 2022Seed$1.2M
- Aug 2020Seed$600K
- Aug 2016Seed$250K
#8
Seed · Fort Worth, Texas · founded 2008 · 8 employees$2Mraised▾
Remote patient monitoring and therapeutic devices for improved health and performance. They empower healthcare providers with remote monitoring tools and chronic care management solutions, facilitating faster recovery, real-time insights, and new revenue streams. They serve diverse care environments, offering innovative tools that improve patient outcomes and increase reimbursements. Their solutions cater to primary care, specialty practices, long-term care facilities, federally qualified health centers, and sports performance settings. They provide smart, connected care solutions that enable proactive, personalized care anytime, anywhere. Their offerings include remote patient monitoring, chronic care management, principal care management, and remote therapeutic monitoring. They offer wearable sensors and devices that track gait, symmetry, range of motion, and other vital signs. These tools are designed for remote rehabilitation, fall detection, and overall health monitoring, supporting both touchless and traditional remote patient monitoring approaches. They provide digital health solutions that help providers deliver better care and unlock new revenue through remote engagement.
- Jul 2018Seed$914.8K
- May 2015Seed$25K
- Jan 2014Seed$773K
- Oct 2012Seed$23.5K
#9
Seed · Fort Worth, Texas · founded 2021 · 9 employees$725Kraised▾
Developer of surgical loupes and optical devices. The company offers an eyepiece is an electro-optical device that captures and processes a light field and the XR Digital Loupes system for visualization during surgeries.
- Mar 2022Seed$725K
#10
Series A · Fort Worth, Texas · founded 2010 · 130 employees$3.1Mraised▾
SteadMed Medical has a portfolio of products catering to acute and chronic wounds, skin and incontinence care. They also partner with other technology companies to market their products in North America. They work with wound care centres, hospitals, home health agencies and nursing homes.
- Jun 2011Series A$3.1M
#11
Seed · Fort Worth, Texas · founded 2015$1.3Mraised▾
Developing innovative phospholipid bound nanoparticle formulations for drug delivery, focusing on pharmaceutical advancements. The company specializes in research and development, creating novel solutions for injectable therapeutics. They are dedicated to improving drug delivery systems through advanced technologies. The company collaborates with partners to enhance manufacturing processes and expand market reach. Their work contributes to the field of nanoparticle therapeutics, aiming to provide better treatment options. The company is involved in scientific presentations and knowledge sharing within the pharmaceutical community.
- Jun 2016Seed$341.7K
- Mar 2016Grant (prize money)$220.7K
- Apr 2015Seed$1M
#12
Seed · Fort Worth, Texas · founded 2015 · 2 employees$863.2Kraised▾
Delicious, low-sugar gummy vitamins for the whole family's health. They provide high-quality, great-tasting, benefit-based supplements. Their gummy vitamins are gluten-free, vegetarian, naturally colored & flavored, and allergen-free. They focus on benefit-based functions that are easy and enjoyable to take. They offer a range of gummy vitamins formulated for various needs, including support for women's health, bone health, heart health, and energy. They also offer a GLP-1 support product. They have a subscription service. They are committed to providing vitamins that are vegetarian and engineered with robust ingredients like pectin. They prioritize health and satisfaction, designing gummy vitamins to be good for you and tantalize your taste buds with natural colors and flavors. They offer cart, login, account, search, and contact options on their website.
- Apr 2020Seed$263.2K
- Sep 2015Seed$600K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.